Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial

NCT01557166 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01557166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01557166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
June 7, 2012
Completion date
June 17, 2013
Enrollment
359 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

metabolism and nutrition disorder, obesity, obstructive sleep apnoea